DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Kopetz S, McDonough SL, Morris VK. et al.
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG 1406).
J Clin Oncol 2017;
35: 520
We do not assume any responsibility for the contents of the web pages of other providers.